PT

Paturi Thrinadh

Active Director Designated Partner DIN 07093744
DIN 07093744 First appointment May 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Paturi Thrinadh

Data last updated:

Paturi Thrinadh is a Designated Partner at Ecleaf Pharmaceuticals Llp (since 2015). The company operates in Pharma.

DIN 07093744
Primary Designation Designated Partner
Industry Pharma
First Appointment 15 May 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 May 20152015Active

Board colleagues of Paturi Thrinadh

NameDINCompanyDesignation
Nagendra Babu Somarowthu07093728Ecleaf Pharmaceuticals LlpDesignated Partner
Sudheer Kumar Nekkanti07093735Ecleaf Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ecleaf Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Paturi Thrinadh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paturi Thrinadh

Paturi Thrinadh currently holds 1 directorship: Ecleaf Pharmaceuticals Llp (Designated Partner, since 15 May 2015).

Paturi Thrinadh was first appointed on 15 May 2015 as Designated Partner at Ecleaf Pharmaceuticals Llp.

The current boards of Paturi Thrinadh's companies include Nagendra Babu Somarowthu (Ecleaf Pharmaceuticals Llp), Sudheer Kumar Nekkanti (Ecleaf Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available